Delivery Order SPE2DB20D2104-SPE2DB24FMBLL

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,560,221,584 units of spironolactone 50mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,393.26 and is a firm fixed price delivery order that runs through March 13, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Spironolactone 50 mg tablets to the Defense Logistics Agency (DLA). The $1,528.36 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 11, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,478,971 units of 100mg Spironolactone tablets over a term ending on March 7, 2025. The $2,031.08 Firm Fixed Price contract was awarded on March 6, 2025 by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.09 firm fixed-price delivery order is for the supply of 4,564,961,020 units of Spironolactone 50 mg tablets. The award has a completion date of June 21, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $4,788.96 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,353,066 units of 50 mg Spironolactone tablets. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,715.11 firm fixed-price delivery order is for the supply of 4557842237 - Spironolactone 100 mg Tablets, 100 per bottle. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a wide range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,298,445 tablets of the drug Spironolactone 50 mg. The contract has a ceiling value of $1,405.94 and is a delivery order with a firm fixed price. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,146.78, is a firm fixed price delivery order for the supply of 4,563,906,332 units of Spironolactone 50 mg tablets. The contract has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and has...
This federal contract award, identified as SPE2DB20D2104|SPE2DB23FR35D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,106.76 firm-fixed-price delivery order is for the supply of 4559306255 - Spironolactone 50 mg tablets. The contract has an ultimate completion date of December 8, 2022 and was awarded on December 7, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Spironolactone 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.38, is a firm fixed-price delivery order with an ultimate completion date of October 12, 2022. It was awarded on October 11, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMBLL
    Delivery Order

This federal contract award for $1,361.40 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,565,804 units of the drug Spironolactone 50 mg Tablet, with a completion date of September 16, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:16 AM